Cite
601 - Gene Editing/Gene Therapies: ENGINEERING HEK293T CELL LINES TO EXPRESS NUCLEASE FOR DNA CLEARANCE IN LENTIVIRAL VECTOR PRODUCTION.
MLA
Ali, S., et al. “601 - Gene Editing/Gene Therapies: ENGINEERING HEK293T CELL LINES TO EXPRESS NUCLEASE FOR DNA CLEARANCE IN LENTIVIRAL VECTOR PRODUCTION.” Cytotherapy (Elsevier Inc.), vol. 24, no. 5, May 2022, p. S138. EBSCOhost, https://doi.org/10.1016/S1465-3249(22)00365-6.
APA
Ali, S., Rivera, M., Ward, J., Keshavarz-Moore, E., Mason, C., Qasim, W., & Nesbeth, D. (2022). 601 - Gene Editing/Gene Therapies: ENGINEERING HEK293T CELL LINES TO EXPRESS NUCLEASE FOR DNA CLEARANCE IN LENTIVIRAL VECTOR PRODUCTION. Cytotherapy (Elsevier Inc.), 24(5), S138. https://doi.org/10.1016/S1465-3249(22)00365-6
Chicago
Ali, S., M. Rivera, J. Ward, E. Keshavarz-Moore, C. Mason, W. Qasim, and D. Nesbeth. 2022. “601 - Gene Editing/Gene Therapies: ENGINEERING HEK293T CELL LINES TO EXPRESS NUCLEASE FOR DNA CLEARANCE IN LENTIVIRAL VECTOR PRODUCTION.” Cytotherapy (Elsevier Inc.) 24 (5): S138. doi:10.1016/S1465-3249(22)00365-6.